BSE filing, NSE: BUILDPRO. Summary written from the filing by ALFA Finder's alert engine.
Shankara Buildpro Ltd: key numbers
- Share price
- ₹217.60
- Market cap
- ₹2,638 Cr
- Revenue (annual)
- ₹6,826 Cr
- Net profit (annual)
- ₹127.7 Cr
- P/E (TTM)
- 20.1×Sector 31.7×
- Promoter holding
- 40.18%+0.00% QoQ
- FII holding
- 7.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shankara Buildpro Ltd
All →Shankara Buildpro Board Meeting Date
SHANKARA BUILDPRO LIMITED will hold a board meeting on 05 Nov 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. Trading window closes 01 Oct to 09 Nov 2026.
Shankara Buildpro Stock Split
Shankara Buildpro Ltd has fixed October 8, 2026, as the record date for its 1:5 stock split, reducing the face value from Rs 10 to Rs 2.
Shankara Buildpro Stock Split
Shankara Buildpro Limited received new ISIN activation from NSDL and CDSL for its equity shares following the previously approved stock split effective October 8, 2026.
Shankara Buildpro Capital Structure Change
Shankara Buildpro Limited fixed October 8, 2026, as the record date for its 1:5 stock split. This action sub-divides share face value from Rs. 10 to Rs. 2.
Shankara Buildpro Annual General Meeting
Shankara Buildpro Limited successfully passed a resolution via postal ballot to split its equity share face value from ₹10 to ₹2.
Shankara Buildpro Capital Structure Change
Shankara Buildpro Ltd announced a sub-division of its equity shares from a face value of ₹10 to ₹2 each to enhance market liquidity.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.